Anti-brain cholinergic auto antibodies from primary Sjögren syndrome sera modify simultaneously cerebral nitric oxide and prostaglandin biosynthesis

International Immunopharmacology

Volumn 7, Issue 12, 2007, Pages 1535-1543

  Orman, Betina ^a   Sterin Borda, Leonor ^a,b   De Couto Pita, Alejandra ^a   Reina, Silvia ^a   Borda, Enri ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Antibodies; COX 1 mRNA; COX 2 mRNA; eNOS; mAChR; Nitric oxide synthase; nNOS; Prostaglandin E2; Sj gren syndrome

Indexed keywords

AUTOANTIBODY; BRAIN ANTIBODY; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; IMMUNOGLOBULIN G; MUSCARINIC RECEPTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHOLIPASE A2; PROSTAGLANDIN E2;

ADULT; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRONTAL CORTEX; GENE EXPRESSION; HUMAN; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; SJOEGREN SYNDROME;

ADULT; ANIMALS; AUTOANTIBODIES; CEREBRAL CORTEX; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOGLOBULIN G; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUSCARINIC ANTAGONISTS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHOLIPASES A2; PIPERIDINES; PIRENZEPINE; RATS; RATS, WISTAR; RECEPTORS, MUSCARINIC; SJOGREN'S SYNDROME;

EID: 34848889053     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.07.018     Document Type: Article

References (28)

1. Tsubota K., Kaido M., Yagi Y., Fujihara T., and Shimmura S. Diseases associated with ocular surface abnormalities: the importance of reflex tearing. Br J Ophthalmol 83 (1999) 89-91
2. Ferguson D.B. The flow rate and composition of human labial gland saliva. Arch Oral Biol 44 (1999) S11-S14
3. Fox P.C., and Speight P.M. Current concepts of auto immune exocrinopathy immunologic mechanism in the salivary pathology of Sjögren Syndrome. Curr Opin Rheumatol 7 (1996) 144-158
4. Delalande S., de Seze J., and Fauchais A.L. Neurologic manifestations in primary Sjögren Syndrome: a study of 82 patients. Medicine (Baltimore) 83 (2004) 280-291
5. Barendregt P.J., van Den Bent M.J., and van Raaij-Van Den Aarssen V.J. Involvement of the peripheral nervous system in primary Sjögren's syndrome. Ann Rheum Dis 60 (2001) 876-881
6. Malinow K., Molina R., Gordon B., Selnes O., Provost T., and Alexander E. Neuropsychiatric dysfunction in primary Sjögren Syndrome. Ann Intern Med 103 (1985) 344-349
7. Belin C., Moroni C., and Caillat-Vigneron N. Central nervous system involvement in Sjögren's syndrome: evidence from neuropsychological testing and HMPAO-SPECT. Ann Med Interne (Paris) 150 (1999) 598-604
8. Valtysdottir S.T., Gudbjornsson B., and Lindqvist U. Anxiety and depression in patients with Sjögren syndrome. J Rheumatol 27 (2000) 165-169
9. Stone J.H., and Francis H.W. Immune-mediated inner ear disease. Curr Opin Rheumatol 12 (2000) 32-40
10. Reina S., Sterin-Borda L., Orman B., and Borda E. Auto antibodies against cerebral muscarinic cholinoceptors in Sjögren syndrome: functional and pathological implications. J Neuroimmunol 150 (2004) 107-115
11. Berra A., Sterin-Borda L., Bacman S., and Borda E. Role of salivary IgA in patogénesis of Sjögren Syndrome. Clin Immunol 104 (2002) 49-57
12. Tandon R., Shipley J.E., Greden J.G., Mann N.A., Eisner W.H., and Goodson J.A. Muscarinic cholinergic hyperactivity in schizophrenia: relationship in positive and negative symptoms. Schizophr Res 4 (1991) 23-30
13. Sterin-Borda L., Ganzinelli S., Berra A., and Borda E. Novel insight into the mechanisms involved in the regulation of the m1 muscarinic receptor, iNOS and nNOS mRNA levels. Neuropharmacology 45 (2003) 260-269
14. Orman B., Reina S., Borda E., and Sterin-Borda L. Signal transduction underlying carbachol-induced PGE2 generation and COX-1 mRNA expression of rat brain. Neuropharmacology 48 (2005) 757-765
15. Mollace W., Muscoli C., Masini E., Cuzzocrea S., and Salvemini D. Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Pharmacol Rev 57 (2005) 217-252
16. Liberatore G.T., Jackson-Lewism V., Vukosavic S., Mandir A.S., Vila M., McAuliffe W.G., et al. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med 5 (1999) 1403-1409
17. Cao C., Matsumura K., Yamagata K., and Watanabe Y. Endothelial cells of the rat brain vaculature express cyclooxygenase 2 mRNA in response to systemic interleukin 1 beta: a possible site of prostaglandin synthesis responsible for fiver. Brain Res 733 (1996) 263-272
18. Breder C.D., and Saper C.D. Expression of inducible cyclooxigenase mRNA in mouse brain after systemic administration of bacterial lipopolysaccharide. Brain Res 713 (1996) 64-69
19. + entry in HEK293 cells is independent of phospholipase C. J Biol Chem 273 (1998) 32636-32643
20. Vitali C., Bombardieri S., and Moutsopoulos H.M. Preliminary criteria for the classification of Sjögren syndrome. Arthritis Rheum 36 (1993) 340-347
21. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-(Delta Delta C(1)) method. Methods 25 (2001) 402-408
22. Lafitte C. Neurological manifestations in Sjögren syndrome. Arch Neurol 57 (2000) 411-413
23. Faraone S.V., Biederman J., Spencer T., Wilens T., Scidman L.J., Mick E., et al. Attention-deficit/hyperactivity disorder in adults: an overview. Biol Psychiatry 48 (2000) 9-20
24. Von der Kammer H., Demilaray C., Andresen B., Albrecht C., Mayhaus M., and Nitsch R.M. Regulation of gene expression by muscarinic acetylcholine receptors. Biochem Soc Symp 67 (2001) 131-140
25. Borda T., Genaro A.M., Sterin-Borda L., and Cremaschi G. Involvement of endogenous nitric oxide signaling system in brain muscarinic acetylcholine receptor activation. J Neural Transm 105 (1998) 193-204
26. 2 production and neurodegeneration in cortical and hippocampal cell cultures. Brain Res 908 (2001) 1-9
27. Schwab J.M., Nguyen T.D., Postler E., Meyermann R., and Schluesener H.J. Selective accumulation of COX-1 expressing microglia cell/macrophages in lesions of human focal cerebral ischemia. Acta Neuropathol 99 (2000) 609-614
28. Minghetti L., and Levi G. Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide progress. Neurobiology 54 (1998) 99-125